Inhibitors of checkpoint kinases

Details for Australian Patent Application No. 2006212951 (hide)

Owner Merck & Co., Inc.

Inventors Yang, Feng; Arrington, Kenneth L.; Huang, Shaei Y.; Garbaccio, Robert M.; Fraley, Mark E.; Lindsley, Craig W.; Steen, Justin T.

Agent Spruson & Ferguson

Pub. Number AU-A-2006212951

PCT Pub. Number WO2006/086255

Priority 60/651,110 08.02.05 US

Filing date 3 February 2006

Wipo publication date 17 August 2006

International Classifications

C07D 235/06 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

A61K 31/4184 (2006.01)

Event Publications

26 July 2007 PCT application entered the National Phase

  PCT publication WO2006/086255 Priority application(s): WO2006/086255

11 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006212960-Process for the production of crosslinked polymer comprising low VOCproducing silane crosslinker and resulting crosslinked polymer

2006212947-Targeted duct injection for SO3 control